Related Experiment Video

Updated: Jul 6, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage

H D Chae1, B M Kim, U J Yun

  • 1National Research Laboratory, Department of Microbiology, Dankook University College of Medicine, Cheonan, Korea.

Oncogene
|March 18, 2008
PubMed

Insights

Actin damage in p53-deficient tumors triggers apoptosis via Bim. Loss of p53 or p21 disrupts cell cycle regulation, leading to polyploidy and cell death, highlighting a novel therapeutic target.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Actin depolymerization agents induce Bim-mediated apoptosis in p53-deficient tumors.
  • The molecular mechanisms driving this apoptosis in p53-deficient cells remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular pathway of Bim-mediated apoptosis in p53-deficient tumor cells following actin damage.
  • To investigate the roles of p53, p21, and cyclin-dependent kinases (CDKs) in this process.

Main Methods:

  • Utilized actin inhibitors and gene knockout strategies (p53, p21).
  • Assessed protein levels of p53, p21, and Bim.
  • Measured Cdk2 and Cdc2 kinase activity.
  • Investigated the effects of Bcl-x(L) expression and dominant-negative Cdk2 (Cdk2dn).

Main Results:

  • Actin inhibitors increased p53 and p21, inactivating Cdk2 and Cdc2.
  • p53- or p21-knockout cells showed sustained CDK activity, multinucleation, polyploidy, and apoptosis.
  • Bcl-x(L) expression inhibited apoptosis and promoted polyploidy.
  • Cdk2 inhibition suppressed multinucleation, Bim expression, and apoptosis.

Conclusions:

  • Bim-mediated apoptosis in actin-damaged, p53-deficient cells is driven by Cdk2 deregulation and cell cycle dysregulation.
  • The absence of functional p53 leads to uncontrolled CDK activity, promoting apoptosis.
  • Targeting Cdk2 may offer a therapeutic strategy for p53-deficient tumors experiencing actin damage.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.